(Press-News.org) DALLAS, Nov. 17, 2025 — Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease and impacts an estimated 1 in 500 people in the U.S., according to the American Heart Association, a relentless force changing the future of health for everyone everywhere. Because many cases go undetected and untreated until acute symptoms occur, the Association is scaling up its efforts to improve diagnosis and treatment of HCM.
HCM is a thickening of the lower main pumping chamber of the heart (the left ventricle). It is a chronic disease that can get worse over time and lead to poorer quality of life and long-term complications, including atrial fibrillation, stroke and heart failure. Despite its serious implications, care for HCM remains fragmented, with inconsistent standards and limited early detection.
To further address these gaps, the American Heart Association is expanding its existing initiative to improve HCM systems of care and standardize how people with HCM are identified, assessed, referred and treated. With new support from Cytokinetics, the program will grow to include:
an increased number of sites participating in a national HCM Registry powered by Get With The Guidelines®;
broader certification opportunities for referring centers and personnel;
introduction of patient support services at select HCM sites; and
a prospective implementation pilot of the Association’s HCM detection algorithm.
The new, matching support from Cytokinetics builds on a national effort designed to unify and elevate consistent standards of care for HCM patients financially supported by founding sponsor Bristol Myers Squibb.
“Hypertrophic cardiomyopathy can be an insidious disease, with some people having no obvious symptoms, while others may only feel symptoms with exercise or exertion,” said Anjali Owens, M.D., volunteer co-chair of the American Heart Association’s HCM initiative and director of the Center for Inherited Cardiovascular Disease at the University of Pennsylvania Perelman School of Medicine. “This initiative represents an essential step toward a unified approach to HCM care, ultimately aiming to improve patient outcomes, enhance quality of life and reduce the risks associated with the disease. Integrated commitment across the system of care is critical to success.”
“Our longstanding commitment to tackling cardiovascular diseases by discovering and developing innovative medical therapies compels us to support the American Heart Association on this important initiative to create a consistent standard of care for people with hypertrophic cardiomyopathy,” said Fady I. Malik, M.D., Ph.D., Cytokinetics’ executive vice president of research and development. “Because HCM can be complex to identify and treat, we are proud to support the initiative’s focus on advancing care and improving outcomes for those affected.”
To stay up to date on the latest science and evidence-based guidelines on HCM care, visit heart.org/HCMregistry.
The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content and policy positions. Overall financial information is available here.
Additional Resources:
Hypertrophic Cardiomyopathy Roundtable Report
AHA HCM Registry, Recognition, and Site Certification Initiative | AHAtv
Health Lesson: Know Your Family Health History
###
About the American Heart Association
The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.
END
Expanded effort will help standardize, improve care for hypertrophic cardiomyopathy
With additional support, American Heart Association initiative seeks to close gaps in diagnosis and advance care for the most common inherited heart disease, improving outcomes for patients nationwide
2025-11-17
ELSE PRESS RELEASES FROM THIS DATE:
World COPD Day: November 19, 2025
2025-11-17
World COPD Day: Short of Breath, Think COPD
Appropriate diagnosis of COPD can have a very significant public health impact.
For Immediate Release
In support of World COPD Day on November 19, the Global Initiative for Chronic Obstructive Lung Disease (GOLD), is drawing attention to the importance of correctly diagnosing COPD earlier - with the theme ‘Short of Breath, Think COPD’.
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable condition marked by breathlessness, chronic sputum ...
Study shows people support higher taxes after understanding benefits of public goods
2025-11-17
Research overview
A research team led by Associate Professor Tomoko Matsumoto from the Institute of Arts and Sciences at Tokyo University of Science, Japan, along with Associate Professor Daiki Kishishita and Associate Professor Atsushi Yamagishi, both from Hitotsubashi University, Japan, has demonstrated that providing people with information about the universal benefits of public goods significantly increases support for higher taxation. This finding reveals a new mechanism that could contribute to reducing inequality by expanding government size while maintaining tax progressivity.
The ...
Nearly 47 million Americans are at high risk of potential health hazards from fossil fuel infrastructure
2025-11-17
Fossil fuels release pollutants into the air when extracted and burned, but there’s more to their production than massive oil rigs diving deep into the Earth and smoky power plants. Those processes are examples of only the first and last—and generally most visible—moments in a fossil fuel’s five-stage journey.
Between the initial extraction site and the final power-generating facility, oil and gas are also refined to remove impurities, held in storage facilities, and transported from ...
In mice, fertility treatments linked to higher mutations than natural conception
2025-11-17
Mice pups conceived with in vitro fertilization (IVF) in the lab have slightly increased rates of DNA errors, or mutations, compared to pups conceived naturally, a new study on artificial reproductive technologies suggests.
While the results do not directly apply to humans, they highlight the importance of understanding how fertility treatments affect an offspring’s DNA. The research is newly published in the journal Genome Research.
“What we are seeing is a true biological signal, but we cannot make an apples-to-apples comparison relative to what happens in a clinic. Still, the fact that we see this trend ...
Researchers develop first-ever common language for cannabis, hemp aromas
2025-11-17
Researchers have taken a significant step toward creating a standardized language for describing the aromas of cannabis and hemp.
“Aroma plays a key role in how consumers judge cannabis quality, yet until now there’s been no standardized language to describe it,” said Tom Shellhammer, professor of food science and technology at Oregon State University. “This research lays the groundwork for a shared vocabulary that benefits consumers, retailers and growers.”
The study, recently published in PLOS ...
Learning to see after being born blind
2025-11-17
Some babies are born with early blindness due to dense bilateral congenital cataracts, requiring surgery to restore their sight. This period of several months without vision can leave a lasting mark on how the brain processes visual details, but surprisingly little on the recognition of faces, objects, or words. This is the main finding of an international study conducted by neuroscientists at University of Louvain (UCLouvain), in collaboration with Ghent University, KU Leuven, and McMaster University (Canada), published in the prestigious ...
Chronic pain may increase the risk of high blood pressure in adults
2025-11-17
Research Highlights:
Chronic pain may be linked to the development of high blood pressure.
The duration and location of pain was associated with the likelihood of developing high blood pressure. In addition, depression and inflammation explained some of the association between chronic pain and high blood pressure.
These findings highlight the importance of pain management in the prevention and control of high blood pressure, a major risk factor for cardiovascular disease and death, researchers said.
Embargoed until 4 a.m. CT/5 a.m. ET Monday, ...
Reviving exhausted immune cells boosts tumor elimination
2025-11-17
A new study has discovered a molecular signal that tumors exploit to exhaust the T cells meant to destroy them—and how silencing that signal could revive the body’s immunity. The study led by Weill Cornell Medicine researchers was published Nov. 17 in Nature Immunology and shows that tumors not only evade the immune system but can actively reprogram immune cells to stop fighting.
“Our dream is to make immune-based therapies available to every patient. To overcome resistance, we must unlock the power of exhausted T cells, reviving them to destroy cancer. This discovery moves us closer to a future where the immune system itself defeats ...
Can we tap the ocean’s power to capture carbon?
2025-11-17
The oceans have to play a role in helping humanity remove carbon dioxide from the atmosphere to curb dangerous climate warming. But are we ready to scale up the technologies that will do the job?
The answer, according to an expert group reporting to the European Union, is no.
At least, not yet – not until there are measures in place to ensure these technologies, called marine carbon dioxide removal technologies, are doing what they are supposed to do and won’t do more harm than good.
Marine carbon dioxide removal technologies build on the ocean’s ability to ...
Brain stimulation improves vision recovery after stroke
2025-11-17
Each year, thousands of stroke survivors are left with hemianopia, a condition that causes loss of half of their visual field (the “vertical midline”). Hemianopia severely affects daily activities such as reading, driving, or just walking through a crowded space.
There are currently no treatments that can restore lost visual function in hemianopia satisfactorily. Most available options focus on teaching patients how to adapt to loss of vision rather than recovering it. To achieve some degree of recovery, months of intensive neurorehabilitative training are required for only ...
LAST 30 PRESS RELEASES:
Weaving secondary battery electrodes with fibers and tying them like ropes for both durability and performance
Using social media may impair children’s attention
Science briefing: An update on GLP-1 drugs for obesity
Lower doses of immunotherapy for skin cancer give better results
Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility
ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment
A sound defense: Noisy pupae puff away potential predators
Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy
Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes
New findings support a chemo-free approach for treating Ph+ ALL
Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL
University of Cincinnati experts present research at annual hematology event
ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial
ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer
ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors
Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient
Continuous and fixed-duration treatments result in similar outcomes for CLL
Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia
Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease
Roughly one-third of families with children being treated for leukemia struggle to pay living expenses
Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy
IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection
Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients
Emergency departments fall short on delivering timely treatment for sickle cell pain
Study shows no clear evidence of harm from hydroxyurea use during pregnancy
Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease
Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia
Early results suggest exa-cel gene therapy works well in children
NTIDE: Disability employment holds steady after data hiatus
Social lives of viruses affect antiviral resistance
[Press-News.org] Expanded effort will help standardize, improve care for hypertrophic cardiomyopathyWith additional support, American Heart Association initiative seeks to close gaps in diagnosis and advance care for the most common inherited heart disease, improving outcomes for patients nationwide